Is neuroimmunomodulation a future therapeutic approach for sepsis?

被引:33
作者
Kumar, V. [1 ]
Sharma, A. [2 ]
机构
[1] Panjab Univ, Dept Microbiol, Chandigarh 160014, India
[2] Dr YS Parmar Univ, Dept Microbiol, Solan, India
关键词
HPA axis; Neuroimmunomodulation; Peripheral nervous system; Sepsis; Sympathetic nervous system; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TO-BRAIN COMMUNICATION; SYSTEMIC INFLAMMATORY RESPONSE; CORTICOTROPIN-RELEASING FACTOR; VAGUS NERVE; IN-VIVO; RECEPTOR ANTAGONIST; POLYMICROBIAL SEPSIS; ACETYLCHOLINE LEVELS; SYMPATHETIC-NERVE;
D O I
10.1016/j.intimp.2009.10.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is considered as a disease of profoundly and uncontrollably activated innate immune response against bacterial infection or their products Thus, regulation of innate immune response plays a critical role in controlling exaggerated systemic inflammation responsible for sepsis development However, treatment of patients suffering from sepsis or its more severe form (ie more severe sepsis or septic shock) with available antibiotics or immunomodulatory agents did not prove effective in controlling multi organ damage and mortality Therefore it is important to explore cascades of mechanisms associated with pathogenesis of sepsis causing high mortality. The nervous system via peripheral nervous system (PNS) or sympathetic nervous system (SNS) along with hypothalamic pituitary axis (HPA) regulates the innate immune response Thus the nervous system may play an important role in fine tuning and precise regulation of exaggerated innate immune response via different pathways (ie cholinergic pathway activated by vagus nerve stimulation. alpha or beta-adrenergic receptor activation etc.) in sepsis Hence neuroimmunomodulation can be a future approach to treat sepsis. (C) 2009 Elsevier B V All rights reserved
引用
收藏
页码:9 / 17
页数:9
相关论文
共 102 条
[1]   Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation [J].
Abraham, E ;
Matthay, MA ;
Dinarello, CA ;
Vincent, JL ;
Cohen, J ;
Opal, SM ;
Glauser, M ;
Parsons, P ;
Fisher, CJ ;
Repine, JE .
CRITICAL CARE MEDICINE, 2000, 28 (01) :232-235
[2]   Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice [J].
Agelaki, S ;
Tsatsanis, C ;
Gravanis, A ;
Margioris, AN .
INFECTION AND IMMUNITY, 2002, 70 (11) :6068-6074
[3]  
ANNANE D, 2009, INTENS CARE MED, V10, P1395
[4]   Differential expression of syntaxin 1A and 1B by noradrenergic and adrenergic chromaffin cells [J].
Baltazar, G ;
Carvalho, AP ;
Duarte, EP .
NEUROCHEMICAL RESEARCH, 2003, 28 (10) :1453-1457
[5]   Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats [J].
Basa, NR ;
Wang, LX ;
Arteaga, JR ;
Heber, D ;
Livingston, EH ;
Taché, Y .
NEUROSCIENCE LETTERS, 2003, 343 (01) :25-28
[6]  
Bergmann M, 2002, WIEN KLIN WOCHENSCHR, V114, P752
[7]   NEURO-ENDOCRINE, SYMPATHETIC AND METABOLIC RESPONSES INDUCED BY INTERLEUKIN-1 [J].
BERKENBOSCH, F ;
DEGOEIJ, DEC ;
DELREY, A ;
BESEDOVSKY, HO .
NEUROENDOCRINOLOGY, 1989, 50 (05) :570-576
[8]   Pharmacological stimulation of the cholinergic antiinflammatory pathway [J].
Bernik, TR ;
Friedman, SG ;
Ochani, M ;
DiRaimo, R ;
Ulloa, L ;
Yang, H ;
Sudan, S ;
Czura, CJ ;
Ivanova, SM ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (06) :781-788
[9]   IMMUNOREGULATORY FEEDBACK BETWEEN INTERLEUKIN-1 AND GLUCOCORTICOID HORMONES [J].
BESEDOVSKY, H ;
DELREY, A ;
SORKIN, E ;
DINARELLO, CA .
SCIENCE, 1986, 233 (4764) :652-654
[10]  
Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729